COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 1772: Articles 17711-17720  | Next

Efficacy and safety of Ivermectin and Hydroxychloroquine in patients with severe COVID-19. A randomized controlled trial
Beltran-Gonzalez, J. L., Gonzalez-Gamez, M., Mendoza-Enciso, E.-A., Esparza-Maldonado, R. J., Hernanez-Palacios, D., Duenas-Campos, S., Ovalle-Robles, I., Macias-Guzman, M. J., Garcia Diaz, A. L., Gutierrez Pena, C. M., Martinez-Medina, L., Monroy Colin, V. M., Arreola Guerra, J. M. A.
10.1101/2021.02.18.21252037 — Posted: 2021-02-23 Discussion: Onsite | Offsite
The U-shaped association of serum iron level with COVID-19 severity: Is iron a potential therapeutic target?
Tojo, K., Sugawara, Y., Oi, Y., Ogawa, F., Higurashi, T., Yoshimura, Y., Miyata, N., Hayami, H., Yamaguchi, Y., Ishikawa, Y., Takeuchi, I., Tachikawa, N., Goto, T.
10.1101/2021.02.19.21252061 — Posted: 2021-02-23
Healthcare personnel knowledge, motivations, concerns and intentions regarding COVID-19 vaccines: a cross-sectional survey
Jain, V., Doernberg, S. B., Holubar, M., Huang, B., Marquez, C., Brown, L., Rubio, L., Sample, H. A., Bollyky, J., Padda, G., Valdivieso, D., Kempema, A., Leung, C., Sklar, M., Julien, A., Paoletti, M., Jaladanki, S., Wan, E., Ghahremani, J., Chao, J., Weng, Y., Lu, D., Glidden, D., Grumbach, K., Maldonado, Y., Rutherford, G.
10.1101/2021.02.19.21251993 — Posted: 2021-02-23
Antigen production and development of an indirect ELISA based on the nucleocapsid protein to detect human SARS-CoV-2 seroconversion
Conzentino, M. d. S., Forchhammer, K., Souza, E. M., Pedrosa, F. d. O., Nogueira, M. B., Raboni, S. M., Rego, F. G. M., Zanette, D. L., Aoki, M. N., Nardin, J. M., Fornazari, B., Morales, H. M. P., Celedon, P. A. F., Lima, C. V. P., Mattar, S. B., Lin, V. H., Morello, L. G., Marchini, F. K., Bueno, L. B., Reis, R. A., Huergo, L.
10.1101/2021.02.19.21252100 — Posted: 2021-02-23
Reproduction as a Means of Evaluating Policy Models: A Case Study of a COVID-19 Simulation
Chattoe-Brown, E., Gilbert, P. N., Robertson, D. A., Watts, C. J.
10.1101/2021.01.29.21250743 — Posted: 2021-02-23
International travel in times of the COVID-19 pandemic: Evidence from German school breaks
Backhaus, A.
10.1101/2021.02.19.21252062 — Posted: 2021-02-23
Targeting CoV-2 Spike RBD and ACE-2 Interaction with Flavonoids of Anatolian Propolis by in silico and in vitro Studies in terms of possible COVID-19 therapeutics
GULER, H. I., AY SAL, F., CAN, Z., KARA, Y., BELDUZ, A. O., CANAKCI, S., KOLAYLI, S.
10.1101/2021.02.22.432207 — Posted: 2021-02-22
Modeling SARS-CoV-2 infection and its individual differences with ACE2-expressing human iPS cells
Sano, E., Sakamoto, A., Mimura, N., Hirabayashi, A., Muramoto, Y., Noda, T., Yamamoto, T., Takayama, K.
10.1101/2021.02.22.432218 — Posted: 2021-02-22
Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants
Laffeber, C., de Koning, K., Kanaar, R., Lebbink, J.
10.1101/2021.02.22.432357 — Posted: 2021-02-22
Reanalysis of deep-sequencing data from Austria points towards a small SARS-COV-2 transmission bottleneck on the order of one to three virions
Martin, M. A., Koelle, K.
10.1101/2021.02.22.432096 — Posted: 2021-02-22

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).